Conclusions
The analysis of the immunoproteome of H. pylori has already lead to the identification of candidate molecules for vaccine development and of putative diagnostic value. Only 10% of the 600 immunogenic molecules are currently identified. The near future will see this number growing rapidly and is likely to lead to the identification of more useful candidates. From a basic science point of view, the cumulative data will yield insight into general properties of the immune system with regard to its detection threshold when confronted with a microbial pathogen of similar complexity. This information will be valuable for improving current algorithms e.g. for vaccine candidate selection. Technical advances will extend the analysis to the study of conformational epitopes and protein chip technologies may be used to compile the H. pylori species proteome. We anticipate that our understanding of the immunoproteome will help to reduce the complexity of such protein arrays while keeping their likely power for the development of new diagnostic tools.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alm, R. A., Bina, J., Andrews, B. M., Doig, P., Hancock, R. E. and Trust, T. J. 2000, Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect.Immun., 68: 4155–4168
Alm, R. A., Ling, L. S., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., Carmel, G., Tummino, P. J., Caruso, A., Uria-Nickelsen, M., Mills, D. M., Ives, C., Gibson, R., Merberg, D., Mills, S. D., Jiang, Q., Taylor, D. E., Vovis, G. F. and Trust, T. J. 1999, Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature, 397: 176–180
Alm, R. A. and Trust, T. J. 1999, Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes. J Mol Med, 77: 834–846
Andersen, L. P., Espersen, F., Souckova, A., Sedlackova, M. and Soucek, A. 1995, Isolation and preliminary evaluation of a low-molecular-mass antigen preparation for improved detection of Helicobacter pylori immunoglobulin G antibodies. Clin.Diagn.Lab Immunol., 2: 156–159
Andrutis, K. A., Fox, J. G., Schauer, D. B., Marini, R. P., Li, X., Yan, L., Josenhans, C. and Suerbaum, S. 1997, Infection of the ferret stomach by isogenic flagellar mutant strains of Helicobacter mustelae. Infect.Immun., 65: 1962–1966
Appelmelk, B. J., Martin, S. L., Monteiro, M. A., Clayton, C. A., McColm, A. A., Zheng, P., Verboom, T., Maaskant, J. J., van den Eijnden, D. H., Hokke, C. H., Perry, M. B., Vandenbroucke-Grauls, C. M. and Kusters, J. G. 1999, Phase Variation in Helicobacter pylori Lipopolysaccharide due to Changes in the Lengths of Poly(C) Tracts in alpha3-Fucosyltransferase Genes. Infect.Immun., 67: 5361–5366
Bazillou, M., Fendri, C., Castel, O., Ingrand, P. and Fauchere, J. L. 1994, Serum antibody response to the superficial and released components of Helicobacter pylori. Clin.Diagn.Lab Immunol., 1: 310–317
Beier, D. and Frank, R. 2000, Molecular characterization of two-component systems of Helicobacter pylori. J.Bacteriol., 182: 2068–2076
Bereswill, S., Greiner, S., van Vliet, A. H., Waidner, B., Fassbinder, F., Schiltz, E., Kusters, J. G. and Kist, M. 2000, Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori. J.Bacteriol., 182: 5948–5953
Bjorkholm, B. M., Guruge, J. L., Oh, J. D., Syder, A. J., Salama, N., Guillemin, K., Falkow, S., Nilsson, C., Falk, P. G., Engstrand, L. and Gordon, J. I. 2002, Colonization of germ-free transgenic mice with genotyped Helicobacter pylori strains from a case-control study of gastric cancer reveals a correlation between host responses and HsdS components of type I restriction-modification systems. J. Biol. Chem., 277: 34191–34197
Blanchard, T. G., Nedrud, J. G., Reardon, E. S. and Czinn, S. J. 1999, Qualitative and quantitative analysis of the local and systemic antibody response in mice and humans with Helicobacter immunity and infection. J.Infect.Dis., 179: 725–728
Blaser, M. J. and Berg, D. E. 2001, Helicobacter pylori genetic diversity and risk of human disease. J.Clin.Invest, 107: 767–773
Bumann, D., Aksu, S., Wendland, M., Janek, K., Zimny-Arndt, U., Sabarth, N., Meyer, T. F. and Jungblut, P. R. 2002a, Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect.Immun., 70: 3396–3403
Bumann, D., Holland, P., Siejak, F., Koesling, J., Sabarth, N., Lamer, S., Zimny-Arndt, U., Jungblut, P. R. and Meyer, T. F. 2002b, A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening. Infect.Immun., 70: 6494–6498
Bumann, D., Meyer, T. F. and Jungblut, P. R. 2001, Proteome analysis of the common human pathogen Helicobacter pylori. Proteomics., 1: 473–479
Censini, S., Lange, C., Xiang, Z., Crabtree, J. E., Ghiara, P., Borodovsky, M., Rappuoli, R. and Covacci, A. 1996, cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc.Natl.Acad.Sci.U.S.A, 93: 14648–14653
Chen, M., Lee, A. and Hazell, S. 1992, Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model. Lancet, 339: 1120–1121
Crabtree, J. E., Taylor, J. D., Wyatt, J. I., Heatley, R. V., Shallcross, T. M., Tompkins, D. S. and Rathbone, B. J. 1991, Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet, 338: 332–335
Del Giudice, G., Covacci, A., Telford, J. L., Montecucco, C. and Rappuoli, R. 2001, The design of vaccines against Helicobacter pylori and their development. Annual Review of Immunology, 19:523–563
DiPetrillo, M. D., Tibbetts, T., Kleanthous, H., Killeen, K. P. and Hohmann, E. L. 1999, Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine, 18: 449–459
Donahue, J. P., Israel, D. A., Torres, V. J., Necheva, A. S. and Miller, G. G. 2002, Inactivation of a Helicobacter pylori DNA methyltransferase alters dnaK operon expression following host-cell adherence. FEMS Microbiol.Lett., 208: 295–301
Donati, M., Moreno, S., Storni, E., Tucci, A., Poli, L., Mazzoni, C., Varoli, O., Sambri, V., Farencena, A. and Cevenini, R. 1997, Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis. Clin.Diagn.Lab Immunol., 4: 478–482
Eaton, K. A., Suerbaum, S., Josenhans, C. and Krakowka, S. 1996, Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect.Immun., 64: 2445–2448
El-Omar, E. M., Carrington, M., Chow, W. H., McColl, K. E., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C. C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J. F. J. and Rabkin, C. S., 2001, Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404: 398–402
Enroth, H., Akerlund, T., Sillen, A. and Engstrand, L. 2000, Clustering of clinical strains of Helicobacter pylori analyzed by two-dimensional gel electrophoresis. Clin.Diagn.Lab Immunol., 7: 301–306
Ernst, P. B. and Gold, B. D. 2000, The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu.Rev.Microbiol., 54: 615–640
Falush, D., Wirth, T., Linz, B., Pritchard, J. K., Stephens, M., Kidd, M., Blaser, M. J., Graham, D. Y., Vacher, S., Perez-Perez, G. I., Yamaoka, Y., Megraud, F., Otto, K., Reichard, U., Katzowitsch, E., Wang, X., Achtman, M. and Suerbaum, S. 2003, Traces of human migrations in Helicobacter pylori populations. Science, 299: 1582–1585
Feldman, R. A., Eccersley, A. J. and Hardie, J. M. 1998, Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio. Br.Med.Bull., 54: 39–53
Ferrero, R. L. and Labigne, A. 2001, Helicobacter pylori vaccine development in the post-genomic era: can in silico translate to in vivo. Scand.J.Immunol., 53: 443–448
Figueiredo, C., Machado, J. C., Pharoah, P., Seruca, R., Sousa, S., Carvalho, R., Capelinha, A. F., Quint, W., Caldas, C., van Doorn, L. J., Carneiro, F. and Sobrinho-Simoes, M. 2002, Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J.Natl.Cancer Inst., 94: 1680–1687
Gerhard, M., Lehn, N., Neumayer, N., Boren, T., Rad, R., Schepp, W., Miehlke, S., Classen, M. and Prinz, C. 1999, Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc.Natl.Acad.Sci.U.S.A, 96: 12778–12783
Gonzalez, C. A., Sala, N. and Capella, G. 2002, Genetic susceptibility and gastric cancer risk. Int.J.Cancer, 100: 249–260
Graham, D. Y. and Yamaoka, Y. 2000, Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter., 5 Suppl: S3–S9
Graham, J. E., Peek, R. M., Jr., Krishna, U. and Cover, T. L. 2002, Global analysis of Helicobacter pylori gene expression in human gastric mucosa. Gastroenterology, 123: 1637–1648
Guruge, J. L., Schalen, C., Nilsson, I., Ljungh, A., Tyszkiewicz, T., Wikander, M. and Wadstrom, T. 1990, Detection of antibodies to Helicobacter pylori cell surface antigens. Scand.J.Infect.Dis., 22: 457–465
Haas, G., Karaali, G., Ebermayer, K., Metzger, W. G., Lamer, S., Zimny-Arndt, U., Diescher, S., Goebel, U. B., Vogt, K., Roznowski, A. B., Wiedenmann, B. J., Meyer, T. F., Aebischer, T. and Jungblut, P. R. 2002, Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics., 2: 313–324
Hook-Nikanne, J., Perez-Perez, G. I. and Blaser, M. J. 1997, Antigenic characterization of Helicobacter pylori strains from different parts of the world. Clin.Diagn.Lab Immunol., 4: 592–597
Hu, L. T., Foxall, P. A., Russell, R. and Mobley, H. L. 1992, Purification of recombinant Helicobacter pylori urease apoenzyme encoded by ureA and ureB. Infect.Immun., 60: 2657–2666
Iaquinto, G., Todisco, A., Giardullo, N., D’Onofrio, V., Pasquale, L., De Luca, A., Andriulli, A., Perri, F., Rega, C., De Chiara, G., Landi, M., Taccone, W., Leandro, G. and Figura, N. 2000, Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig.Liver Dis., 32: 378–383
Ilver, D., Arnqvist, A., Ogren, J., Frick, I. M., Kersulyte, D., Incecik, E. T., Berg, D. E., Covacci, A., Engstrand, L. and Boren, T. 1998, Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science, 279: 373–377
Joyce, E. A., Chan, K., Salama, N. R. and Falkow, S. 2002, Redefining bacterial populations: a post-genomic reformation. Nat.Rev.Genet., 3: 462–473
Jungblut, P., Thiede, B., Zimny-Arndt, U., Muller, E. C., Scheler, C., Wittmann-Liebold, B. and Otto, A. 1996, Resolution power of two-dimensional electrophoresis and identification of proteins from gels. Electrophoresis, 17: 839–847
Jungblut, P. R., Bumann, D., Haas, G., Zimny-Arndt, U., Holland, P., Lamer, S., Siejak, F., Aebischer, A. and Meyer, T. F. 2000a, Comparative proteome analysis of Helicobacter pylori. Mol.Microbiol., 36: 710–725
Jungblut, P. R., Bumann, D., Haas, G., Zimny-Arndt, U., Holland, P., Lamer, S., Siejak, F., Aebischer, A. and Meyer, T. F. 2000b, Comparative proteome analysis of helicobacter pylori. Mol.Microbiol., 36: 710–725
Kamradt, A. E., Greiner, M., Ghiara, P. and Kaufmann, S. H. 2000, Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants. Microbes.Infect., 2: 593–597
Keenan, J., Oliaro, J., Domigan, N., Potter, H., Aitken, G., Allardyce, R. and Roake, J. 2000, Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect.Immun., 68: 3337–3343
Kim, N., Weeks, D. L., Shin, J. M., Scott, D. R., Young, M. K. and Sachs, G. 2002, Proteins released by Helicobacter pylori in vitro. J.Bacteriol., 184: 6155–6162
Kimmel, B., Bosserhoff, A., Frank, R., Gross, R., Goebel, W. and Beier, D. 2000, Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect.Immun., 68: 915–920
Kleanthous, H., Lee, C. K. and Monath, T. P. 1998, Vaccine development against infection with Helicobacter pylori. Br.Med Bull., 54: 229–241
Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C. and Walker, R. I. 2001, Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect.Immun., 69: 3581–3590
Kreiss, C., Buclin, T., Cosma, M., Corthesy-Theulaz, I. and Michetti, P. 1996, Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection. Lancet, 347: 1630–1631
Lan, R. and Reeves, P. R. 2000, Intraspecies variation in bacterial genomes: the need for a species genome concept. Trends Microbiol., 8: 396–401
Lee, A. 1999, Animal models of Helicobacter infection. Mol Med Today, 5: 500–501
Lee, A., O’Rourke, J., De Ungria, M. C., Robertson, B., Daskalopoulos, G. and Dixon, M. F. 1997, A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology, 112: 1386–1397
Lock, R. A., Coombs, G. W., McWilliams, T. M., Pearman, J. W., Grubb, W. B., Melrose, G. J. and Forbes, G. M. 2002, Proteome analysis of highly immunoreactive proteins of Helicobacter pylori. Helicobacter, 7: 175–182
Loffeld, R. J. and van der Hulst, R. W. 2002, Helicobacter pylori and gastro-oesophageal reflux disease: association and clinical implications. To treat or not to treat with anti-H. pylori therapy? Scand.J.Gastroenterol.Suppl, 15–18
Machado, J. C., Pharoah, P., Sousa, S., Carvalho, R., Oliveira, C., Figueiredo, C., Amorim, A., Seruca, R., Caldas, C., Carneiro, F. and Sobrinho-Simoes, M. 2001, Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology, 121: 823–829
Mahdavi, J., Sonden, B., Hurtig, M., Olfat, F. O., Forsberg, L., Roche, N., Angstrom, J., Larsson, T., Teneberg, S., Karlsson, K. A., Altraja, S., Wadstrom, T., Kersulyte, D., Berg, D. E., Dubois, A., Petersson, C., Magnusson, K. E., Norberg, T., Lindh, F., Lundskog, B. B., Arnqvist, A., Hammarstrom, L. and Boren, T. 2002, Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science, 297: 573–578
Mai, U. E., Perez-Perez, G. I., Allen, J. B., Wahl, S. M., Blaser, M. J. and Smith, P. D. 1992, Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J.Exp.Med., 175: 517–525
Marshall, B. J. and Warren, J. R. 1984, Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1: 1311–1315
McAtee, C. P., Fry, K. E. and Berg, D. E. 1998a, Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by “proteome” technologies. Helicobacter., 3: 163–169
McAtee, C. P., Lim, M. Y., Fung, K., Velligan, M., Fry, K., Chow, T. and Berg, D. E. 1998b, Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by two-dimensional gel electrophoresis, sequence analysis, and serum profiling. Clin.Diagn.Lab Immunol., 5: 537–542
McAtee, C. P., Lim, M. Y., Fung, K., Velligan, M., Fry, K., Chow, T. P. and Berg, D. E. 1998c, Characterization of a Helicobacter pylori vaccine candidate by proteome techniques. J.Chromatogr.B Biomed.Sci.Appl., 714: 325–333
Michetti, P., Kreiss, C., Kotloff, K. L., Porta, N., Blanco, J. L., Bachmann, D., Herranz, M., Saldinger, P. F., Corthesy-Theulaz, I., Losonsky, G., Nichols, R., Simon, J., Stolte, M., Ackerman, S., Monath, T. P. and Blum, A. L. 1999, Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology, 116: 804–812
Mitchell, H. M., Hazell, S. L., Li, Y. Y. and Hu, P. J. 1996, Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am.J.Gastroenterol., 91: 1785–1788
Nilsson, C. L., Larsson, T., Gustafsson, E., Karlsson, K. A. and Davidsson, P. Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry. Anal.Chem.2000.May.1.;72.(9.):2148.-53., 72: 2148–2153
Nilsson, I. and Utt, M. 2002, Separation and surveys of proteins of Helicobacter pylori. J.Chromatogr.B Analyt.Technol.Biomed.Life Sci., 771: 251–260
Nilsson, I., Utt, M., Nilsson, H. O., Ljungh, A. and Wadstrom, T. 2000, Two-dimensional electrophoretic and immunoblot analysis of cell surface proteins of spiral-shaped and coccoid forms of Helicobacter pylori. Electrophoresis, 21: 2670–2677
O’Toole, P. W., Logan, S. M., Kostrzynska, M., Wadstrom, T. and Trust, T. J. 1991, Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori. J.Bacteriol., 173: 505–513
Opazo, P., Muller, I., Rollan, A., Valenzuela, P., Yudelevich, A., Garcia-de, l. G., Urra, S. and Venegas, A. 1999, Serological response to Helicobacter pylori recombinant antigens in Chilean infected patients with duodenal ulcer, non-ulcer dyspepsia and gastric cancer. APMIS, 107: 1069–1078
Peek, R. M., Jr. and Blaser, M. J. 2002, Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat.Rev.Cancer, 2: 28–37
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Arico, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., Galeotti, C. L., Luzzi, E., Manetti, R., Marchetti, E., Mora, M., Nuti, S., Ratti, G., Santini, L., Savino, S., Scarselli, M., Storni, E., Zuo, P., Broeker, M., Hundt, E., Knapp, B., Blair, E., Mason, T., Tettelin, H., Hood, D. W., Jeffries, A. C., Saunders, N. J., Granoff, D. M., Venter, J. C., Moxon, E. R., Grandi, G. and Rappuoli, R. Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing. Science, 287: 1816–1820
Pun, T., Hochstrasser, D. F., Appel, R. D., Funk, M., Villars-Augsburger, V. and Pellegrini, C. 1988, Computerized classification of two-dimensional gel electrophoretograms by correspondence analysis and ascendant hierarchical clustering. Appl.Theor.Electrophor., 1: 3–9
Sabarth, N., Hurwitz, R., Meyer, T. F. and Bumann, D. 2002a, Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy. Infect.Immun., 70: 6499–6503
Sabarth, N., Lamer, S., Zimny-Arndt, U., Jungblut, P. R., Meyer, T. F. and Bumann, D. 2002b, Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis. J. Biol. Chem., 277: 27896–27902
Salama, N., Guillemin, K., McDaniel, T. K., Sherlock, G., Tompkins, L. and Falkow, S. 2000, A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc.Natl.Acad.Sci.U.S.A, 97: 14668–14673
Scarlato, V., Delany, I., Spohn, G. and Beier, D. 2001, Regulation of transcription in Helicobacter pylori: simple systems or complex circuits? Int.J.Med.Microbiol., 291: 107–117
Schmidt, F., Schmid, M., Mattow, J., Pleissner, K.-P. and Jungblut, P. R. 2003, Iterations are the key for exhaustive analysis of peptide mass fingerprints from proteins separated by two dimensional elecrophoresis. JASMS, 2003: in press
Schmitt, W. and Haas, R. 1994, Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol.Microbiol., 12: 307–319
Tannaes, T., Dekker, N., Bukholm, G., Bijlsma, J. J. and Appelmelk, B. J. 2001, Phase variation in the Helicobacter pylori phospholipase A gene and its role in acid adaptation. Infect.Immun., 69: 7334–7340
Telford, J. L., Ghiara, P., DelľOrco, M., Comanducci, M., Burroni, D., Bugnoli, M., Tecce, M. F., Censini, S., Covacci, A., Xiang, Z. and. 1994, Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J.Exp.Med., 179: 1653–1658
Thompson, L. J., Guillemin, K., Falkow, S. and Lee, A. 2002, DNA microarray analysis of the global gene expression of Helicobacter pylori during the growth cycle. 4th Western pacific Helicobacter Congress, 8.2.4
Tomb, J. F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., Nelson, K., Quackenbush, J., Zhou, L., Kirkness, E. F., Peterson, S., Loftus, B., Richardson, D., Dodson, R., Khalak, H. G., Glodek, A., McKenney, K., Fitzegerald, L. M., Lee, N., Adams, M. D. and Venter, J. C. 1997, The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature, 388: 539–547
Unge, P. 1999, Antibiotic treatment of Helicobacter pylori infection. Curr.Top.Microbiol.Immunol., 241: 261–300
Utt, M., Nilsson, I., Ljungh, A. and Wadstrom, T. 2002, Identification of novel immunogenic proteins of Helicobacter pylori by proteome technology. J.Immunol.Methods, 259: 1–10
Watanabe, T., Tada, M., Nagai, H., Sasaki, S. and Nakao, M. 1998, Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology, 115: 642–648
Xiang, Z., Bugnoli, M., Ponzetto, A., Morgando, A., Figura, N., Covacci, A., Petracca, R., Pennatini, C., Censini, S., Armellini, D. and. 1993, Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur.J.Clin.Microbiol.Infect.Dis., 12: 739–745
Yamaoka, Y., Kikuchi, S., el Zimaity, H. M., Gutierrez, O., Osato, M. S. and Graham, D. Y. 2002, Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology, 123: 414–424
Yamaoka, Y., Kwon, D. H. and Graham, D. Y. 2000, A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc.Natl.Acad.Sci.U.S.A, 97: 7533–7538
Zevering, Y., Jacob, L. and Meyer, T. F. 1999, Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut, 45: 465–474
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Aebischer, T., Krah, A., Bumann, D., Jungblut, P.R., Meyer, T.F. (2004). The Immunoproteome of H. pylori . In: Hondermarck, H. (eds) Proteomics: Biomedical and Pharmaceutical Applications. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2323-5_13
Download citation
DOI: https://doi.org/10.1007/1-4020-2323-5_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-2322-4
Online ISBN: 978-1-4020-2323-1
eBook Packages: Springer Book Archive